Tumors of female reproductive systemTumors of female reproductive systemОпухоли женской репродуктивной системы1994-40981999-8627Publishing House ABV Press18810.17650/1994-4098-2011-0-4-8-12MAMMOLOGY. TOPICAL ISSUEМАММОЛОГИЯ. АКТУАЛЬНАЯ ТЕМАPlace of organ-sparing surgery in the treatment of early breast cancer in elderly and senile patientsМесто органосохраняющих операций в лечении раннего рака молочной железы у пациенток пожилого и старческого возрастаRodionovV. V.РодионовВ. В.
Russian Federation
dr.valery.rodionov@gmail.comMidlenkoA. A.МидленкоА. А.
Russian Federation
SuyetinA. V.СуетинА. В.
Russian Federation
RodionovaM. V.РодионоваМ. В.
Russian Federation
Regional Clinical Oncology Dispensary, UlyanovskГУЗ Областной клинический онкологический диспансер, УльяновскUlyanovsk State UniversityУльяновский государственный университет18112011481220082014200820142011https://ojrs.abvpress.ru/ojrs/article/view/188

The paper analyzes the results of treatment in elderly and senile patients with early breast cancer in relation to the scope of surgical treat- ment. The study enrolled 425 patients receiving the treatment as sector resection, the latter with lymph node dissection, and r adical mastec- tomy. According to the results of a follow-up, a group of patients treated by sector resection showed the best relapse-free sur vival rates and minimum breast cancer mortality.

Проведен анализ результатов лечения больных ранним раком молочной железы пожилого и старческого возраста в зависимости от объема оперативного лечения. В исследование включено 425 пациенток, получавших лечение в объеме секторальной резекции, секторальной резекции с лимфодиссекцией и радикальной мастэктомии. По результатам последующего наблюдения, группа пациенток, получавших лечение в объеме секторальной резекции, характеризовалась наилучшими показателями безрецидивной выживаемости и минимальным уровнем смертности от рака молочной железы.

breast cancerelderly agesurgical treatmentorgan-sparing operationsрак молочной железыпожилой возрастхирургическое лечениеорганосохраняющие операции1. Greenlee R.T., Hill-Harmon M.B., Murray T. et al. Cancer statistics. CA Cancer J Clin 2001;51:15–36.Greenlee R.T., Hill-Harmon M.B., Murray T. et al. Cancer statistics. CA Cancer J Clin 2001;51:15–36.2. Yancik R. Cancer burden in the aged: An epidemiologic and demographic overview. Cancer 1997;80:1273–83.Yancik R. Cancer burden in the aged: An epidemiologic and demographic overview. Cancer 1997;80:1273–83.3. Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: First results of international breast cancer study group trial 10-93. J Clin Oncol 2008;24(3):337–44.Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: First results of international breast cancer study group trial 10-93. J Clin Oncol 2008;24(3):337–44.4. Halsted W.S. The results of radical operations for the cure of cancer of the breast. Ann Surg 1907;46:1–5.Halsted W.S. The results of radical operations for the cure of cancer of the breast. Ann Surg 1907;46:1–5.5. Fisher B., Redmond C., Fisher E.R. et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 1985;312:674–81.Fisher B., Redmond C., Fisher E.R. et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 1985;312:674–81.6. Gervasoni J.E. Jr., Taneja C., Chung M.A. et al. Axillary dissection in the context of the biology of lymph node metastases. Am J Surg 2000;180:278–83.Gervasoni J.E. Jr., Taneja C., Chung M.A. et al. Axillary dissection in the context of the biology of lymph node metastases. Am J Surg 2000;180:278–83.7. Veronesi U., Paganelli G., Viale G. et al. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst 1999;91:368–73.Veronesi U., Paganelli G., Viale G. et al. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst 1999;91:368–73.8. Tabar L., Smith R.A., Vitak B. et al. Mammographic screening: a key factor in the control of breast cancer. Cancer J 2003;9:15–27.Tabar L., Smith R.A., Vitak B. et al. Mammographic screening: a key factor in the control of breast cancer. Cancer J 2003;9:15–27.9. Menard S., Bufalino R., Rilke F. et al. Prognosis based on primary breast carcinoma instead of pathological nodal status. Br J Cancer 1994;70:709–12.Menard S., Bufalino R., Rilke F. et al. Prognosis based on primary breast carcinoma instead of pathological nodal status. Br J Cancer 1994;70:709–12.10. De Laurentiis M., Gallo C., De Placido S. et al. A predictive index of axillary nodal involvement in operable breast cancer. Br J Cancer 1996;73:1241–7.De Laurentiis M., Gallo C., De Placido S. et al. A predictive index of axillary nodal involvement in operable breast cancer. Br J Cancer 1996;73:1241–7.11. Ravdin P.M., De Laurentiis M., Vendely T. et al. Prediction of axillary lymph node status in breast cancer patients by use of prognostic indicators. J Natl Cancer Inst 1994;86:1171–5.Ravdin P.M., De Laurentiis M., Vendely T. et al. Prediction of axillary lymph node status in breast cancer patients by use of prognostic indicators. J Natl Cancer Inst 1994;86:1171–5.